Dishman Pharmaceuticals & Chemicals
BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
News on Dishman Pharmaceuticals & Chemicals
Buy Dishman Pharma; target of Rs 285: Systematix
2.48 pm | 17 Feb 2017 | Source: Moneycontrol.com
Systematix is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 285 in its research report dated February 14...
Dishman Pharmaceuticals declares interim dividend
4.08 pm | 13 Feb 2017 | Source: Moneycontrol.com
Dishman Pharmaceuticals and Chemicals has informed that a Meeting of the Board of Directors of the Company was held on February 13, 2017, has declared...
Dishman Pharma's Q3 results on February 13, 2017
4.22 pm | 04 Feb 2017 | Source: Moneycontrol.com
Dishman Pharmaceuticals has informed that a meeting of the board of Directors of the company will be held on February 13, 2017 to consider and take on...
Top buzzing midcap stocks to trade on February 2
12.44 pm | 02 Feb 2017 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - M&M, Tata Motors, Bajaj Auto, CCL Prodcuts, Dishman ...
Dishman Pharma receives EIR report from USFDA
11.42 am | 02 Feb 2017 | Source: PTI
"The company's Bavla facility was successfully inspected by the USFDA in July, 2016, which was intimated to the stock exchanges on July 9, 2016. In th...
Quick Links for Dishman Pharmaceuticals & Chemicals
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.